BioElectronics Corporation (BIEL)
- Previous Close
0.0003 - Open
0.0002 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0003 - 52 Week Range
0.0001 - 0.0007 - Volume
1,402,123 - Avg. Volume
26,105,741 - Market Cap (intraday)
4.941M - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Apr 22, 2024 - May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.
www.bielcorp.comRecent News: BIEL
Performance Overview: BIEL
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIEL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIEL
Valuation Measures
Market Cap
6.18M
Enterprise Value
6.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-18.01%
Return on Assets (ttm)
-33.67%
Return on Equity (ttm)
--
Revenue (ttm)
1.61M
Net Income Avi to Common (ttm)
-289.82k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
925
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-554.29k